Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
Eh0V56eVaAkjphyP
